Skip to content

Preoperative high-frequency QRS parameters and left bundle branch area pacing response in non-ischemic left bundle branch block patients: An exploratory study.

Nov 2026 · International Journal of Cardiology · pp. 135047 · 0 citations · 28 references
Medicine

Abstract

Background

Left bundle branch area pacing (LBBP) has become a preferred as a novel strategy for cardiac resynchronization therapy (CRT). High-frequency QRS (HFQRS) analysis can detect subtle ventricular depolarization abnormalities that are not identifiable on standard electrocardiography and may provide novel markers for predicting response to LBBP.

Methods

We prospectively enrolled 58 consecutive patients with non-ischemic cardiomyopathy and left bundle branch block (LBBB) who underwent guideline-directed LBBP between 2022 and 2025. LBBP response was defined as an absolute increase in left ventricular ejection fraction (LVEF) >10% at 6-month follow-up. Preprocedural HFQRS parameters were quantitatively analyzed, including mean HFQRS amplitude and the high-frequency morphological index (HFMI).

Results

Forty-three patients (74.1%) met the criteria for LBBP response. Responders had significantly lower anterior mean HFQRS amplitude (1.61 ± 0.59 vs. 2.60 ± 1.01 μV, P = 0.002) and higher anterior HFMI (24.7% vs. 16.1%, P = 0.002) than non-responders. Anterior mean amplitude showed the strongest predictive value for LBBP response (AUC = 0.800, 95% CI 0.656-0.944). Patients with lower anterior mean amplitude demonstrated better event-free survival (log-rank P = 0.011). In multivariable analysis, lower anterior mean amplitude independently predicted greater LVEF improvement (β = -0.474, P = 0.003) and was associated with more pronounced reverse remodeling (P = 0.001).

Conclusion

In patients with non-ischemic LBBB undergoing LBBP, reduced anterior mean HFQRS amplitude is independently associated with improved ventricular recovery and a higher likelihood of response to resynchronization therapy. HFQRS analysis may provide a useful noninvasive tool for preprocedural risk stratification and patient selection in LBBP.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.